1. Expert Rev Gastroenterol Hepatol 2018 Oct;12(10):951-960.
doi: 10.1080/17474124.2018.1522248. Epub 2018 Sep 20.
Elobixibat for the treatment of constipation
Victor Chedid 1, Priya Vijayvargiya 1, Michael Camilleri 1 2

2. Lancet Gastroenterol Hepatol 2018 Aug;3(8):537-547.
doi: 10.1016/S2468-1253(18)30123-7. Epub 2018 May 25.
Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial
Atsushi Nakajima 1, Mitsunori Seki 2, Shinya Taniguchi 3, Akira Ohta 2, Per-Göran Gillberg 4, Jan P Mattsson 4, Michael Camilleri 5

3.Expert Opin Pharmacother 2018 Aug;19(12):1381-1388.
doi: 10.1080/14656566.2018.1508450. Epub 2018 Aug 21.
Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation
Philip B Miner Jr 1


4. Gut. 2017 Sep;66(9):1611-1622.
doi: 10.1136/gutjnl-2016-311835. Epub 2016 Jun 10.
Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis
Alfred D Nelson 1, Michael Camilleri 1, Sakkarin Chirapongsathorn 1, Priya Vijayvargiya 1, Nelson Valentin 1, Andrea Shin 2, Patricia J Erwin 1, Zhen Wang 3, M Hassan Murad 3